SAN FRANCISCO — During the COVID-19 pandemic, people with chronic lung diseases, including asthma and COPD, were more likely to delay or avoid medical care compared with the general population or those with other COVID-19 risk factorsAt the American Thoracic Society International Conference, Jane C. Fazio, MD, pulmonary critical care fellow at the David Geffen School of Medicine at UCLA,
In addition to suffering with cystic fibrosis, patients with this condition often contract lung infections that are difficult to treat; however, an upcoming study may…
The FDA has cleared an investigational new drug application for a small molecule therapeutic to treat those with Fragile X syndrome, according to the manufacturer.In…
Approximately 77,000 people in the U.S. have hypoparathyroidism due to absent or subphysiological levels of parathyroid hormone. About 75% of cases are the result of…
ATLANTA — Pregnant women with fewer economic resources may still be at elevated risk for CVD despite a low score on a CVD risk calculator,…
ATLANTA — Data from a small substudy with cardiac MRI suggest acoramidis may improve both cardiac mass and function for adults with symptomatic transthyretin amyloid…
As the eye care world approaches a possible shortage of ophthalmologists, the steady hand of robotic surgical tools could be a welcome addition for patients…
The American Society of Nephrology has called on Congress to increase funding for the U.S. transplant system by $8 million in fiscal year 2025, according…
The FDA has approved subcutaneous administration of Takeda Pharmaceuticals’ Entyvio for maintenance therapy in adult patients with moderate-to-severe Crohn’s disease following induction therapy via IV…
BOSTON — More than 40% of patients with difficult-to-treat pathogens were prescribed older, generic agents despite the FDA approval of several new gram-negative antibiotics, findings…
BOSTON — “We should be embracing [AI] and trying to make this a priority to get this right, because I don’t know any alternative to…
